Predictors of racial differences in weight loss: the PROPEL trial
CONCLUSIONS: Strategies specifically targeting engagement, such as improving session attendance and self-weighing behaviors, among African American individuals are needed to support more equitable weight losses over extended time periods.PMID:38058232 | DOI:10.1002/oby.23936 (Source: Obesity)
Source: Obesity - December 7, 2023 Category: Eating Disorders & Weight Management Authors: Robert L Newton Dachaun Zhang William D Johnson Corby K Martin John W Apolzan Kara D Denstel Phillip J Brantley Terry C Davis Connie Arnold Daniel F Sarpong Eboni G Price-Haywood Carl J Lavie Tina K Thethi Peter T Katzmarzyk Source Type: research
Predictors of racial differences in weight loss: the PROPEL trial
CONCLUSIONS: Strategies specifically targeting engagement, such as improving session attendance and self-weighing behaviors, among African American individuals are needed to support more equitable weight losses over extended time periods.PMID:38058232 | DOI:10.1002/oby.23936 (Source: Obesity)
Source: Obesity - December 7, 2023 Category: Eating Disorders & Weight Management Authors: Robert L Newton Dachaun Zhang William D Johnson Corby K Martin John W Apolzan Kara D Denstel Phillip J Brantley Terry C Davis Connie Arnold Daniel F Sarpong Eboni G Price-Haywood Carl J Lavie Tina K Thethi Peter T Katzmarzyk Source Type: research
Predictors of racial differences in weight loss: the PROPEL trial
CONCLUSIONS: Strategies specifically targeting engagement, such as improving session attendance and self-weighing behaviors, among African American individuals are needed to support more equitable weight losses over extended time periods.PMID:38058232 | DOI:10.1002/oby.23936 (Source: Obesity)
Source: Obesity - December 7, 2023 Category: Eating Disorders & Weight Management Authors: Robert L Newton Dachaun Zhang William D Johnson Corby K Martin John W Apolzan Kara D Denstel Phillip J Brantley Terry C Davis Connie Arnold Daniel F Sarpong Eboni G Price-Haywood Carl J Lavie Tina K Thethi Peter T Katzmarzyk Source Type: research
Early- and later-stage persistence with antiobesity medications: A retrospective cohort study
CONCLUSIONS: Later-stage persistence with AOM varies considerably based on the drug and the weight loss at 6 months.PMID:38053443 | DOI:10.1002/oby.23952 (Source: Obesity)
Source: Obesity - December 6, 2023 Category: Eating Disorders & Weight Management Authors: Hamlet Gasoyan Elizabeth R Pfoh Rebecca Schulte Phuc Le Michael B Rothberg Source Type: research
Plant-based dietary patterns and genetic susceptibility to obesity in the CARTaGENE cohort
CONCLUSIONS: These findings suggest that components of a plant-based diet and a shift away from animal products, specifically meat, might be beneficial for nutrition interventions, particularly among individuals with higher genetic risk of obesity.PMID:38057558 | DOI:10.1002/oby.23944 (Source: Obesity)
Source: Obesity - December 6, 2023 Category: Eating Disorders & Weight Management Authors: Guiomar Masip Atheer Attar Daiva E Nielsen Source Type: research
Early- and later-stage persistence with antiobesity medications: A retrospective cohort study
CONCLUSIONS: Later-stage persistence with AOM varies considerably based on the drug and the weight loss at 6 months.PMID:38053443 | DOI:10.1002/oby.23952 (Source: Obesity)
Source: Obesity - December 6, 2023 Category: Eating Disorders & Weight Management Authors: Hamlet Gasoyan Elizabeth R Pfoh Rebecca Schulte Phuc Le Michael B Rothberg Source Type: research
Plant-based dietary patterns and genetic susceptibility to obesity in the CARTaGENE cohort
CONCLUSIONS: These findings suggest that components of a plant-based diet and a shift away from animal products, specifically meat, might be beneficial for nutrition interventions, particularly among individuals with higher genetic risk of obesity.PMID:38057558 | DOI:10.1002/oby.23944 (Source: Obesity)
Source: Obesity - December 6, 2023 Category: Eating Disorders & Weight Management Authors: Guiomar Masip Atheer Attar Daiva E Nielsen Source Type: research
Game changers: do new medications make lifestyle-based treatment of obesity obsolete?
Obesity (Silver Spring). 2023 Dec 3. doi: 10.1002/oby.23962. Online ahead of print.ABSTRACTHistorically, obesity was viewed as a lifestyle disease, with an associated lifestyle solution, and approaches that embody the "eat less, move more" idea have dominated obesity treatment recommendations for over half a century. Meanwhile, the prevalence and severity of obesity continue to increase globally. Enter the so-called "game changers": glucagon-like peptide-1 receptor agonists. In the media frenzy around these and other new antiobesity medications in the pipeline, lifestyle-based treatment researchers and practitioners may fi...
Source: Obesity - December 3, 2023 Category: Eating Disorders & Weight Management Authors: Kristina H Lewis Justin B Moore Jamy D Ard Source Type: research
Game changers: do new medications make lifestyle-based treatment of obesity obsolete?
Obesity (Silver Spring). 2023 Dec 3. doi: 10.1002/oby.23962. Online ahead of print.ABSTRACTHistorically, obesity was viewed as a lifestyle disease, with an associated lifestyle solution, and approaches that embody the "eat less, move more" idea have dominated obesity treatment recommendations for over half a century. Meanwhile, the prevalence and severity of obesity continue to increase globally. Enter the so-called "game changers": glucagon-like peptide-1 receptor agonists. In the media frenzy around these and other new antiobesity medications in the pipeline, lifestyle-based treatment researchers and practitioners may fi...
Source: Obesity - December 3, 2023 Category: Eating Disorders & Weight Management Authors: Kristina H Lewis Justin B Moore Jamy D Ard Source Type: research
Game changers: do new medications make lifestyle-based treatment of obesity obsolete?
Obesity (Silver Spring). 2023 Dec 3. doi: 10.1002/oby.23962. Online ahead of print.ABSTRACTHistorically, obesity was viewed as a lifestyle disease, with an associated lifestyle solution, and approaches that embody the "eat less, move more" idea have dominated obesity treatment recommendations for over half a century. Meanwhile, the prevalence and severity of obesity continue to increase globally. Enter the so-called "game changers": glucagon-like peptide-1 receptor agonists. In the media frenzy around these and other new antiobesity medications in the pipeline, lifestyle-based treatment researchers and practitioners may fi...
Source: Obesity - December 3, 2023 Category: Eating Disorders & Weight Management Authors: Kristina H Lewis Justin B Moore Jamy D Ard Source Type: research
Follistatin-like 1 is a myokine regulating lipid mobilization during endurance exercise and recovery
CONCLUSIONS: Fstl1 is a myokine facilitating lipid mobilization during and after endurance exercise through DIP2a-mediated lipolytic effects in adipocytes.PMID:38018497 | DOI:10.1002/oby.23949 (Source: Obesity)
Source: Obesity - November 29, 2023 Category: Eating Disorders & Weight Management Authors: Ji Sun Nam Su-Jeong Park Chul Woo Ahn Eun-Suk Cho Hee-Joo Kim YuSik Kim Source Type: research
Follistatin-like 1 is a myokine regulating lipid mobilization during endurance exercise and recovery
CONCLUSIONS: Fstl1 is a myokine facilitating lipid mobilization during and after endurance exercise through DIP2a-mediated lipolytic effects in adipocytes.PMID:38018497 | DOI:10.1002/oby.23949 (Source: Obesity)
Source: Obesity - November 29, 2023 Category: Eating Disorders & Weight Management Authors: Ji Sun Nam Su-Jeong Park Chul Woo Ahn Eun-Suk Cho Hee-Joo Kim YuSik Kim Source Type: research
Follistatin-like 1 is a myokine regulating lipid mobilization during endurance exercise and recovery
CONCLUSIONS: Fstl1 is a myokine facilitating lipid mobilization during and after endurance exercise through DIP2a-mediated lipolytic effects in adipocytes.PMID:38018497 | DOI:10.1002/oby.23949 (Source: Obesity)
Source: Obesity - November 29, 2023 Category: Eating Disorders & Weight Management Authors: Ji Sun Nam Su-Jeong Park Chul Woo Ahn Eun-Suk Cho Hee-Joo Kim YuSik Kim Source Type: research
Follistatin-like 1 is a myokine regulating lipid mobilization during endurance exercise and recovery
CONCLUSIONS: Fstl1 is a myokine facilitating lipid mobilization during and after endurance exercise through DIP2a-mediated lipolytic effects in adipocytes.PMID:38018497 | DOI:10.1002/oby.23949 (Source: Obesity)
Source: Obesity - November 29, 2023 Category: Eating Disorders & Weight Management Authors: Ji Sun Nam Su-Jeong Park Chul Woo Ahn Eun-Suk Cho Hee-Joo Kim YuSik Kim Source Type: research
Roux-en-Y versus one-anastomosis gastric bypass (RYSA study): weight loss, metabolic improvements, and nutrition at 1 year after surgery, a multicenter randomized controlled trial
CONCLUSIONS: RYGB and OAGB were comparable in weight loss, metabolic improvement, remission of diabetes and hypercholesterolemia, and nutrition at 1-year follow-up. Vitamin D-25 deficiency was more prevalent with OAGB, whereas reduction in antihypertensive medications and hypertension was greater with RYGB. There is no need to change the current practices of RYGB in favor of OAGB.PMID:37987183 | DOI:10.1002/oby.23852 (Source: Obesity)
Source: Obesity - November 21, 2023 Category: Eating Disorders & Weight Management Authors: Sini Heinonen Tuure Saarinen Sanna Meril äinen Henna Sammalkorpi Anne K Penttil ä Minna Koivikko Pertti Siira Jaro Karppinen Ulla S äiläkivi Milla Roseng ård-Bärlund Vesa Koivukangas Kirsi H Pietil äinen Anne Juuti Source Type: research
